PATENT CLAIM ANALYSIS

Application Number: 16143682
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["600", "476000"]

Abstract:
In certain aspects, the invention relates to processes for using renally excretable optical agents to detect one or more tissues of the renal system of a surgical patient. In certain aspects, the invention relates to a kit including a biocompatible composition containing one or more optical agents and instructions for using the optical agent(s) in a process of the present invention.

Claim (Index 20):
The process of  claim 19 , wherein the pyrazine molecule is administered intravenously.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 97.0
- Lexical Diversity: 1.65854
- Patent Class: 600.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14919967', '11995270', '11721186', '14047733', '15178720']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5306578974400872
- 35 USC 102 Novelty (BERT): 0.5389270023034132
- Combined Prediction Score: 0.5314848079264198
- Mean Citation Score: 332.918408
- Max Citation Score: 571.0967400000002
- Similarity Product: 246.76873866909213

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test